Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (60 total)
-
Créateur: FDA
Sujet: Research
Type d'élément: Lien hypertexte
Date de la dernière mise à jour: 2023-05-12
Description: The Emergency Use Authorization (EUA) authority allows FDA to help strengthen the nation’s public health protections against chemical, biological, radiological, and nuclear (CBRN) threats including infectious diseases, by facilitating the… -
Créateur: FDA
Sujet: Research
Type d'élément: Lien hypertexte
Date de la dernière mise à jour: 2022-07-20
Description: Current Federal law requires that a drug be the subject of an approved marketing application before it is transported or distributed across state lines. Because a sponsor will probably want to ship the investigational drug to clinical investigators… -
Créateur: NETEC
Sujet: Treatment & Care
Type d'élément: Lien hypertexte
Date de la dernière mise à jour: 2023-02-24
Description: This NETEC blog post reviews 10 Takeaways for Clinicians for Marburg Virus Disease (MVD), MVD Therapeutics and Vaccine Candidates, and additional resources. -
Créateur: CDC
Sujet: Treatment & Care
Type d'élément: Lien hypertexte
Date de la dernière mise à jour: 2021-02-26
Description: Information and guidance on the treatment of Ebola patients, including therapeutics and supportive care. -
Créateur: NETEC
Sujet: Emergency Management
Type d'élément: Webinaire
Date de la dernière mise à jour: 2022-11-09
Description: This NETEC webinar will discuss the current landscape of influenza in the United States and the predictions for this year’s flu season. Additional topics will include available therapeutics to treat common symptoms and co-infections and infection… -
Créateur: WHO
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2022-08-19
Description: The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. -
Créateur: Ya Gao, Yunli Zhao, Gordon Guyatt, Robert Fowler, Richard Kojan, Long Ge, Jinhui Tian, Collaborators; Qiukui Hao
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2022-07-05
Description: Specific treatments targeting Ebola virus are crucial in managing Ebola virus disease. To support the development of clinical practice guidelines on medications for Ebola virus disease, we aimed to evaluate the efficacy and safety of therapies for… -
Créateur: Editor Bruce Hawkins
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2019
Description: The purpose of these guidelines is to describe a standardized approach for the management of investigational drug products by the clinical research pharmacy, pharmaceutical industry, and cooperative and research network groups. -
Créateur: Schafer, Adam, Rui Xiong, Laura Cooper, Raghad Nowar, Hyun Lee, Yangfeng Li, Benjamin E. Ramirez, Norton P. Peet, Michael Caffrey, Gregory R. J. Thatcher, Erica Ollmann Saphire, Han Cheng, and Lijun Rong.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-02-04
Description: Many small molecules have been identified as entry inhibitors of filoviruses. However, a lack of understanding of the mechanism of action for these molecules limits further their development as anti-filoviral agents. Here we provide evidence that… -
Créateur: Arabi, Yaseen M., Ayed Y. Asiri, Abdullah M. Assiri, Hanan H. Balkhy, Ali Al Bshabshe, Majed Al Jeraisy, Yasser Mandourah, Mohamed H. A. Azzam, Abdulhadi M. Bin Eshaq, Sameera Al Johani, Shmeylan Al Harbi, Hani A. A. Jokhdar, Ahmad M. Deeb, Ziad A.…
Sujet: Laboratory
Type d'élément: Publication
Date de la dernière mise à jour: 2020-10-07
Description: Whether combined treatment with recombinant interferon beta-1b and lopinavir–ritonavir reduces mortality among patients hospitalized with Middle East respiratory syndrome (MERS) is unclear.
